HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician.

AbstractAIMS:
To test whether the dose-dependent motivation-suppressing effect of baclofen in animals could be transposed to humans, and suppress craving and sustain abstinence.
METHODS:
Neurologists safely use up to 300 mg/day (10 times the dosage currently used for alcohol dependence) of high-dose oral baclofen, to control spasticity, in order to avoid invasive therapy. I am a physician with alcohol dependence and comorbid anxiety. I self-prescribed high-dose baclofen, starting at 30 mg/day, with 20 mg increments every third day and an (optional) additional 20-40 mg/day for cravings.
RESULTS:
Cravings became easier to combat. After reaching the craving-suppression dose of 270 mg/day (3.6 mg/kg) after 5 weeks, I became and have remained free of alcohol dependence symptoms effortlessly for the ninth consecutive month. Anxiety is well controlled. Somnolence disappeared with a dosage reduction to 120 mg/day, now used for the eighth consecutive month.
CONCLUSIONS:
High-dose baclofen induced complete and prolonged suppression of symptoms and consequences of alcohol dependence, and relieved anxiety. This model, integrating cure and well-being, should be tested in randomized trials, under medical surveillance. It offers a new concept: medication-induced, dose-dependent, complete and prolonged suppression of substance-dependence symptoms with alleviation of comorbid anxiety.
AuthorsOlivier Ameisen
JournalAlcohol and alcoholism (Oxford, Oxfordshire) (Alcohol Alcohol) 2005 Mar-Apr Vol. 40 Issue 2 Pg. 147-50 ISSN: 0735-0414 [Print] England
PMID15596425 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Baclofen
Topics
  • Alcoholism (drug therapy, prevention & control, psychology)
  • Anxiety Disorders (drug therapy, prevention & control, psychology)
  • Baclofen (administration & dosage)
  • Diagnosis, Dual (Psychiatry)
  • Drug Administration Schedule
  • Humans
  • Male
  • Middle Aged
  • Physician Impairment (psychology)
  • Self Care (methods)
  • Self Disclosure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: